A superagonist variant of peptide MART1/Melan A27-35 elicits anti-melanoma CD8+ T cells with enhanced functional characteristics: implication for more effective immunotherapy.

Source:http://linkedlifedata.com/resource/pubmed/id/9927036

Cancer Res. 1999 Jan 15 59 2 301-6

Download in:

View as

Triples

General Info

PMID
9927036